Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

Neurology. 2015 Apr 21;84(16):1620-1. doi: 10.1212/WNL.0000000000001506. Epub 2015 Mar 25.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural
  • Comment

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Intermediate Filaments*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / cerebrospinal fluid*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Neurofibrils*
  • Propylene Glycols / pharmacology*
  • Sphingosine / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Sphingosine